Jaguar Health (JAGX) Payables (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Payables data on file, last reported at $27.0 million in Q1 2026.

• On a quarterly basis, Payables rose 5.34% year-over-year to $27.0 million in Q1 2026; TTM through Mar 2026 was $27.0 million, a 5.34% increase from a year earlier, with the FY2025 full-year figure at $36.1 million, up 108.53% from the prior year.
• Payables for Q1 2026 stood at $27.0 million, down from $36.1 million in the prior quarter.
• Over the last five years, Payables for JAGX reached as high as $36.1 million in Q4 2025 and fell as low as $8.6 million in Q3 2023.
• Historically, Payables has averaged $19.4 million across 5 years, with a median of $18.0 million in 2022.
• Across the five-year window, Payables jumped 223.73% in 2022 and tumbled 54.63% in 2023, its largest moves.
• Year by year, Payables stood at $21.7 million in 2022, then tumbled by 54.63% to $9.8 million in 2023, then jumped by 76.04% to $17.3 million in 2024, then jumped by 108.53% to $36.1 million in 2025, then slipped by 25.17% to $27.0 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $27.0 million in Q1 2026, $36.1 million in Q4 2025, and $31.6 million in Q3 2025.